An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies, Current Opinion in Pharmacology, vol.24, pp.52-58, 2015. ,
DOI : 10.1016/j.coph.2015.07.005
Eteplirsen in the treatment of Duchenne muscular dystrophy, Drug Design, Development and Therapy, vol.11, pp.533-545, 2017. ,
DOI : 10.2147/DDDT.S97635
Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy, Nature Neuroscience, vol.20, pp.497-499, 2017. ,
DOI : 10.1212/WNL.0000000000002445
Dystrophin: The protein product of the Duchenne muscular dystrophy locus PMID: 3319190 arthritis mouse models, Cell. Mol Ther, vol.51, issue.16, pp.919-928, 1987. ,
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA, Nucleic Acids Research, vol.32, issue.1, pp.346-53, 2004. ,
DOI : 10.1093/nar/gkh187
Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice, Molecular Therapy, vol.14, issue.4, pp.471-475, 2006. ,
DOI : 10.1016/j.ymthe.2006.05.017
Ensembl 2016, Nucleic Acids Research, vol.44, issue.D1, pp.710-716, 2016. ,
DOI : 10.1093/nar/gkv1157
URL : http://doi.org/10.1093/nar/gkv1157
The Human Genome Browser at UCSC, Genome Research, vol.12, issue.6, pp.996-1006, 2002. ,
DOI : 10.1101/gr.229102
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC186604
Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders, Skeletal Muscle, vol.1, issue.1, pp.34-22040608, 2011. ,
DOI : 10.1089/hum.2008.163
URL : https://hal.archives-ouvertes.fr/inserm-00651121
Long-term Exon Skipping Studies With 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models, Mol Ther Nucleic Acids Nucleic Acids, vol.1, pp.43-23344236, 2012. ,
Multiplex Western Blotting System for the Analysis of Muscular Dystrophy Proteins, The American Journal of Pathology, vol.154, issue.4, pp.1017-1022, 1999. ,
DOI : 10.1016/S0002-9440(10)65354-0
Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms, Molecular Therapy, vol.17, issue.3, pp.548-553, 2009. ,
DOI : 10.1038/mt.2008.205
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835096
Design of Phosphorodiamidate Morpholino Oligomers (PMOs) for the Induction of Exon Skipping of the Human DMD Gene, Molecular Therapy, vol.17, issue.3, pp.554-561, 2009. ,
DOI : 10.1038/mt.2008.287
Gene, Human Gene Therapy, vol.23, issue.7, pp.781-790, 2012. ,
DOI : 10.1089/hum.2011.205
Exonic Sequences Provide Better Targets for Antisense Oligonucleotides Than Splice Site Sequences in the Modulation of Duchenne Muscular Dystrophy Splicing, Oligonucleotides, vol.20, issue.2, pp.69-77, 2010. ,
DOI : 10.1089/oli.2009.0215
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle, Nature, vol.333, issue.6172, pp.466-469, 1988. ,
DOI : 10.1038/333466a0
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy, Neuromuscular Disorders, vol.12, issue.1, pp.71-77, 2002. ,
DOI : 10.1016/S0960-8966(02)00086-X
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051, New England Journal of Medicine, vol.357, issue.26, pp.2677-86, 2007. ,
DOI : 10.1056/NEJMoa073108
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients, Human Molecular Genetics, vol.12, issue.8, pp.907-921, 2003. ,
DOI : 10.1093/hmg/ddg100
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy, New England Journal of Medicine, vol.364, issue.16, pp.1513-1522, 2011. ,
DOI : 10.1056/NEJMoa1011367
In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy, PLOS ONE, vol.34, issue.3, pp.1-24, 2015. ,
DOI : 10.1371/journal.pone.0120058.s015
URL : https://hal.archives-ouvertes.fr/hal-01233078
Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript, Molecular Therapy, vol.15, issue.7, pp.1288-96, 2007. ,
DOI : 10.1038/sj.mt.6300095
Functional Analysis of 114 Exon-Internal AONs for Targeted DMD Exon Skipping: Indication for Steric Hindrance of SR Protein Binding Sites, Oligonucleotides, vol.15, issue.4, pp.284-297, 2005. ,
DOI : 10.1089/oli.2005.15.284
The evolution, impact and properties of exonic splice enhancers, Genome Biology, vol.14, issue.12, pp.143-24359918, 2013. ,
DOI : 10.1093/molbev/msp219
Purifying Selection on Splice-Related Motifs, Not Expression Level nor RNA Folding, Explains Nearly All Constraint on Human lincRNAs, Molecular Biology and Evolution, vol.31, issue.12, pp.3164-3183, 2014. ,
DOI : 10.1093/molbev/msu249
Chemical modification and design of anti-miRNA oligonucleotides, Gene Therapy, vol.1, issue.12, pp.1111-1120, 2011. ,
DOI : 10.1261/rna.2533811
Superior silencing by 2',4'- BNA(NC)-based short antisense oligonucleotides compared to 2',4'-BNA/LNA-based apolipoprotein B antisense inhibitors, J Nucleic Acids, vol.2012, p.23056920, 2012. ,
DOI : 10.1155/2012/707323
URL : http://doi.org/10.1155/2012/707323
Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides, Nucleic Acids Research, vol.23, issue.17, pp.3578-3584, 1995. ,
DOI : 10.1093/nar/23.17.3578
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC307240/pdf
Silencing of microRNA families by seed-targeting tiny LNAs, Nature Genetics, vol.442, issue.4, pp.371-378, 2011. ,
DOI : 10.1074/mcp.M800029-MCP200